Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1984-2-15
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-1899
pubmed:author
pubmed:issnType
Print
pubmed:volume
148
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
1136-59
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:6361173-ABO Blood-Group System, pubmed-meshheading:6361173-Adult, pubmed-meshheading:6361173-Animals, pubmed-meshheading:6361173-Antibodies, Bacterial, pubmed-meshheading:6361173-Bacterial Vaccines, pubmed-meshheading:6361173-Child, pubmed-meshheading:6361173-Cross Reactions, pubmed-meshheading:6361173-Humans, pubmed-meshheading:6361173-Infant, pubmed-meshheading:6361173-Meningitis, Pneumococcal, pubmed-meshheading:6361173-Opsonin Proteins, pubmed-meshheading:6361173-Phagocytosis, pubmed-meshheading:6361173-Pneumococcal Infections, pubmed-meshheading:6361173-Pneumococcal Vaccines, pubmed-meshheading:6361173-Polysaccharides, Bacterial, pubmed-meshheading:6361173-Species Specificity, pubmed-meshheading:6361173-Streptococcus pneumoniae, pubmed-meshheading:6361173-Vaccination
pubmed:year
1983
pubmed:articleTitle
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Review, Research Support, Non-U.S. Gov't